{"transactions":[{"id":705829,"issuer":{"id":6983,"kind":"organization","name":"Cingulate Inc."},"owners":[{"id":29538,"kind":"person","name":"Brams Matthew","position":1,"cik":"0001884361","reported_name":"Brams Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2026-07-20T23:32:12.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":26400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: 25% on March 31, 2027 and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vested option only becomes exercisable if the Issuer's NDA for CTx-1301 is approved by the FDA during 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"If the Issuer's NDA for CTx-1301 is not approved by the FDA during 2027, the option, including any vested portion, shall terminate."}],"balance_after":26400,"derivative":{"exercise_price":4.43,"expiration_date":"2036-07-16","underlying":"Common Stock","underlying_shares":26400},"source":{"system":"sec-edgar","filing":"0001493152-26-033967","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862150/000149315226033967/ownership.xml","form_type":"4"}},{"id":705828,"issuer":{"id":6983,"kind":"organization","name":"Cingulate Inc."},"owners":[{"id":29538,"kind":"person","name":"Brams Matthew","position":1,"cik":"0001884361","reported_name":"Brams Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2026-07-20T23:32:12.000Z","date":"2026-07-16","kind":"grant","planned":false,"acquired":true,"shares":53600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: 25% on March 31, 2027 and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date."}],"balance_after":53600,"derivative":{"exercise_price":4.43,"expiration_date":"2036-07-16","underlying":"Common Stock","underlying_shares":53600},"source":{"system":"sec-edgar","filing":"0001493152-26-033967","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862150/000149315226033967/ownership.xml","form_type":"4"}},{"id":848889,"issuer":{"id":6983,"kind":"organization","name":"Cingulate Inc."},"owners":[{"id":29538,"kind":"person","name":"Brams Matthew","position":1,"cik":"0001884361","reported_name":"Brams Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-12T00:13:25.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":1025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Shares otherwise issuable were withheld to satisfy the Reporting Person's tax obligations on the grant described in footnote 1 above."}],"balance_after":8157,"source":{"system":"sec-edgar","filing":"0001493152-26-009719","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862150/000149315226009719/ownership.xml","form_type":"4"}},{"id":848888,"issuer":{"id":6983,"kind":"organization","name":"Cingulate Inc."},"owners":[{"id":29538,"kind":"person","name":"Brams Matthew","position":1,"cik":"0001884361","reported_name":"Brams Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-12T00:13:25.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":4526,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares of common stock were granted pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended, for a portion of the Reporting Person's 2025 bonus."}],"balance_after":9182,"source":{"system":"sec-edgar","filing":"0001493152-26-009719","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862150/000149315226009719/ownership.xml","form_type":"4"}},{"id":912238,"issuer":{"id":6983,"kind":"organization","name":"Cingulate Inc."},"owners":[{"id":29538,"kind":"person","name":"Brams Matthew","position":1,"cik":"0001884361","reported_name":"Brams Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2026-02-11T00:00:19.000Z","date":"2026-02-06","kind":"purchase","planned":false,"acquired":true,"shares":1556,"price":0.1,"value":155.6,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Common stock and warrants were acquired in the Issuer's private placement disclosed in the Current Report on Form 8-K filed with the SEC on January 28, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrant is exercisable upon the Issuer obtaining stockholder approval of the private placement, as required by the Nasdaq rules. The expiration date of the warrant is 36 months after the exercise date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrant is exercisable upon the Issuer obtaining stockholder approval of the private placement, as required by the Nasdaq rules. The expiration date of the warrant is 36 months after the exercise date."}],"balance_after":1556,"derivative":{"exercise_price":5.04,"underlying":"Common Stock","underlying_shares":1556},"source":{"system":"sec-edgar","filing":"0001493152-26-006024","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1862150/000149315226006024/ownership.xml","form_type":"4"}},{"id":912237,"issuer":{"id":6983,"kind":"organization","name":"Cingulate Inc."},"owners":[{"id":29538,"kind":"person","name":"Brams Matthew","position":1,"cik":"0001884361","reported_name":"Brams Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-11T00:00:19.000Z","date":"2026-02-06","kind":"purchase","planned":false,"acquired":true,"shares":1946,"price":5.04,"value":9807.84,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Common stock and warrants were acquired in the Issuer's private placement disclosed in the Current Report on Form 8-K filed with the SEC on January 28, 2026."}],"balance_after":4656,"source":{"system":"sec-edgar","filing":"0001493152-26-006024","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862150/000149315226006024/ownership.xml","form_type":"4"}},{"id":1090043,"issuer":{"id":6983,"kind":"organization","name":"Cingulate Inc."},"owners":[{"id":29538,"kind":"person","name":"Brams Matthew","position":1,"cik":"0001884361","reported_name":"Brams Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2025-07-09T22:00:06.000Z","date":"2025-07-07","kind":"grant","planned":false,"acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: 25% on the one-year anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date."}],"balance_after":52500,"derivative":{"exercise_price":4.42,"expiration_date":"2035-07-07","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001641172-25-018476","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862150/000164117225018476/ownership.xml","form_type":"4"}},{"id":1256061,"issuer":{"id":6983,"kind":"organization","name":"Cingulate Inc."},"owners":[{"id":29538,"kind":"person","name":"Brams Matthew","position":1,"cik":"0001884361","reported_name":"Brams Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2025-02-20T23:00:01.000Z","date":"2025-02-18","kind":"grant","planned":false,"acquired":true,"shares":17630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: 25% on the one-year anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date."}],"balance_after":17630,"derivative":{"exercise_price":4.32,"expiration_date":"2035-02-18","underlying":"Common Stock","underlying_shares":17630},"source":{"system":"sec-edgar","filing":"0001493152-25-007758","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862150/000149315225007758/ownership.xml","form_type":"4"}},{"id":1297812,"issuer":{"id":6983,"kind":"organization","name":"Cingulate Inc."},"owners":[{"id":29538,"kind":"person","name":"Brams Matthew","position":1,"cik":"0001884361","reported_name":"Brams Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2025-01-23T00:00:04.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":2748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option was granted for a portion of Mr. Bram's 2024 bonus."}],"balance_after":2748,"derivative":{"exercise_price":4.76,"exercise_date":"2025-01-17","expiration_date":"2035-01-17","underlying":"Common Stock","underlying_shares":2748},"source":{"system":"sec-edgar","filing":"0001493152-25-003288","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862150/000149315225003288/ownership.xml","form_type":"4"}},{"id":1308257,"issuer":{"id":6983,"kind":"organization","name":"Cingulate Inc."},"owners":[{"id":29538,"kind":"person","name":"Brams Matthew","position":1,"cik":"0001884361","reported_name":"Brams Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2025-01-08T01:30:00.000Z","date":"2024-12-31","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option was granted pursuant to the terms of Mr. Bram's Employment Agreement, as amended."}],"balance_after":1000,"derivative":{"exercise_price":4.93,"exercise_date":"2024-12-31","expiration_date":"2034-12-31","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001493152-25-001274","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862150/000149315225001274/ownership.xml","form_type":"4"}},{"id":1396868,"issuer":{"id":6983,"kind":"organization","name":"Cingulate Inc."},"owners":[{"id":29538,"kind":"person","name":"Brams Matthew","position":1,"cik":"0001884361","reported_name":"Brams Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2024-10-01T22:00:04.000Z","date":"2024-09-30","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option was granted pursuant to the terms of Mr. Bram's Employment Agreement, as amended."}],"balance_after":1000,"derivative":{"exercise_price":5.04,"exercise_date":"2024-09-30","expiration_date":"2034-09-30","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001493152-24-039066","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862150/000149315224039066/ownership.xml","form_type":"4"}},{"id":1463342,"issuer":{"id":6983,"kind":"organization","name":"Cingulate Inc."},"owners":[{"id":29538,"kind":"person","name":"Brams Matthew","position":1,"cik":"0001884361","reported_name":"Brams Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2024-07-03T00:00:17.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option was granted pursuant to the terms of Mr. Bram's Employment Agreement, as amended."}],"balance_after":1000,"derivative":{"exercise_price":0.32,"exercise_date":"2024-06-28","expiration_date":"2034-06-28","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001493152-24-026099","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862150/000149315224026099/ownership.xml","form_type":"4"}},{"id":1480867,"issuer":{"id":6983,"kind":"organization","name":"Cingulate Inc."},"owners":[{"id":29538,"kind":"person","name":"Brams Matthew","position":1,"cik":"0001884361","reported_name":"Brams Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2024-06-13T23:59:46.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":63324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The stock option grant was approved by Cingulate Inc.'s board of directors on March 4, 2024, subject to stockholder approval of Amendment No.1 to the Cingulate Inc. 2021 Omnibus Equity Incentive Plan (the \"Amendment\"). Cingulate's stockholders approved the Amendment on June 11, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as follows: 50% on the six-month anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 30-month period following the initial vesting date."}],"balance_after":63324,"derivative":{"exercise_price":1.18,"expiration_date":"2034-03-04","underlying":"Common Stock","underlying_shares":63324},"source":{"system":"sec-edgar","filing":"0001493152-24-023766","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862150/000149315224023766/ownership.xml","form_type":"4"}},{"id":1556534,"issuer":{"id":6983,"kind":"organization","name":"Cingulate Inc."},"owners":[{"id":29538,"kind":"person","name":"Brams Matthew","position":1,"cik":"0001884361","reported_name":"Brams Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2024-04-01T23:00:17.000Z","date":"2024-03-29","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option was granted pursuant to the terms of Mr. Bram's Employment Agreement, as amended."}],"balance_after":1000,"derivative":{"exercise_price":1.1,"exercise_date":"2024-03-29","expiration_date":"2034-03-29","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001493152-24-012568","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862150/000149315224012568/ownership.xml","form_type":"4"}},{"id":1592036,"issuer":{"id":6983,"kind":"organization","name":"Cingulate Inc."},"owners":[{"id":29538,"kind":"person","name":"Brams Matthew","position":1,"cik":"0001884361","reported_name":"Brams Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2024-03-06T23:00:38.000Z","date":"2024-03-04","kind":"grant","planned":false,"acquired":true,"shares":16676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: 50% on the six-month anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 30-month period following the initial vesting date."}],"balance_after":16676,"derivative":{"exercise_price":1.18,"expiration_date":"2034-03-04","underlying":"Common Stock","underlying_shares":16676},"source":{"system":"sec-edgar","filing":"0001493152-24-009090","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862150/000149315224009090/ownership.xml","form_type":"4"}},{"id":1963519,"issuer":{"id":6983,"kind":"organization","name":"Cingulate Inc."},"owners":[{"id":29538,"kind":"person","name":"Brams Matthew","position":1,"cik":"0001884361","reported_name":"Brams Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2023-03-09T02:01:14.000Z","date":"2023-02-28","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: 25% on the one-year anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.79,"expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001493152-23-007040","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862150/000149315223007040/ownership.xml","form_type":"4"}},{"id":2365826,"issuer":{"id":6983,"kind":"organization","name":"Cingulate Inc."},"owners":[{"id":29538,"kind":"person","name":"Brams Matthew","position":1,"cik":"0001884361","reported_name":"Brams Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2022-03-01T23:00:32.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as follows: 25% on the one-year anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date."}],"balance_after":12500,"derivative":{"exercise_price":1.38,"expiration_date":"2032-02-25","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001493152-22-005780","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862150/000149315222005780/ownership.xml","form_type":"4"}},{"id":2479114,"issuer":{"id":6983,"kind":"organization","name":"Cingulate Inc."},"owners":[{"id":29538,"kind":"person","name":"Brams Matthew","position":1,"cik":"0001884361","reported_name":"Brams Matthew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Medical Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2021-12-09T23:00:39.000Z","date":"2021-12-07","kind":"grant","acquired":true,"shares":4492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments commencing on December 7, 2022."}],"balance_after":4492,"derivative":{"exercise_price":6,"expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":4492},"source":{"system":"sec-edgar","filing":"0001493152-21-031006","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1862150/000149315221031006/ownership.xml","form_type":"4"}}]}